Detalhe da pesquisa
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587254
2.
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future.
Curr Atheroscler Rep
; 24(7): 585-597, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524914
3.
Vitamin K2 Status and Arterial Stiffness Among Untreated Migraine Patients: A Case-Control Study.
Headache
; 60(3): 589-599, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769041
4.
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
N Engl J Med
; 375(25): 2423-2434, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959713
5.
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.
Am Heart J
; 208: 81-90, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580130
6.
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
Circulation
; 135(7): 648-655, 2017 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881569
7.
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
Circulation
; 135(4): 323-333, 2017 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881555
8.
Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients.
Am Heart J
; 198: 84-90, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653652
9.
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial.
J Thromb Thrombolysis
; 45(1): 1-8, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29188425
10.
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
Circulation
; 134(24): 1918-1930, 2016 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881559
11.
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
Am Heart J
; 185: 93-100, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28267480
12.
Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting Following General Anesthesia: A Randomized Clinical Trial.
Anesth Analg
; 124(2): 438-444, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28002167
13.
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.
J Thromb Thrombolysis
; 44(4): 457-465, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905172
14.
EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention.
Eur Heart J
; 37(16): 1296-303, 2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26586786
15.
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction.
Am Heart J
; 180: 22-8, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659879
16.
Medical education in a foreign language and history-taking in the native language in Lebanon - a nationwide survey.
BMC Med Educ
; 16(1): 298, 2016 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27876043
17.
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
Circulation
; 139(9): 1234-1236, 2019 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30802169
18.
Renal function decline in recipients and donors of kidney grafts: role of aortic stiffness.
Am J Nephrol
; 41(1): 57-65, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25662778
19.
D-Dimer elevation and adverse outcomes.
J Thromb Thrombolysis
; 39(1): 55-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25006010
20.
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.
J Am Coll Cardiol
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588930